rs1051421

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000214.3(JAG1):​c.3528C>T​(p.Tyr1176Tyr) variant causes a synonymous change. The variant allele was found at a frequency of 0.253 in 1,614,010 control chromosomes in the GnomAD database, including 53,389 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 4229 hom., cov: 33)
Exomes 𝑓: 0.26 ( 49160 hom. )

Consequence

JAG1
NM_000214.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 5.44

Publications

24 publications found
Variant links:
Genes affected
JAG1 (HGNC:6188): (jagged canonical Notch ligand 1) The jagged 1 protein encoded by JAG1 is the human homolog of the Drosophilia jagged protein. Human jagged 1 is the ligand for the receptor notch 1, the latter is involved in signaling processes. Mutations that alter the jagged 1 protein cause Alagille syndrome. Jagged 1 signalling through notch 1 has also been shown to play a role in hematopoiesis. [provided by RefSeq, Nov 2019]
JAG1 Gene-Disease associations (from GenCC):
  • Alagille syndrome due to a JAG1 point mutation
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • Charcot-Marie-Tooth disease, axonal, Type 2HH
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • tetralogy of fallot
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 20-10639627-G-A is Benign according to our data. Variant chr20-10639627-G-A is described in ClinVar as Benign. ClinVar VariationId is 42478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.277 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JAG1NM_000214.3 linkc.3528C>T p.Tyr1176Tyr synonymous_variant Exon 26 of 26 ENST00000254958.10 NP_000205.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JAG1ENST00000254958.10 linkc.3528C>T p.Tyr1176Tyr synonymous_variant Exon 26 of 26 1 NM_000214.3 ENSP00000254958.4
JAG1ENST00000423891.6 linkn.3394C>T non_coding_transcript_exon_variant Exon 24 of 25 2
JAG1ENST00000617357.1 linkn.*243C>T downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.222
AC:
33775
AN:
152058
Hom.:
4232
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.109
Gnomad AMI
AF:
0.466
Gnomad AMR
AF:
0.284
Gnomad ASJ
AF:
0.287
Gnomad EAS
AF:
0.155
Gnomad SAS
AF:
0.191
Gnomad FIN
AF:
0.216
Gnomad MID
AF:
0.269
Gnomad NFE
AF:
0.278
Gnomad OTH
AF:
0.256
GnomAD2 exomes
AF:
0.243
AC:
61006
AN:
251472
AF XY:
0.244
show subpopulations
Gnomad AFR exome
AF:
0.104
Gnomad AMR exome
AF:
0.277
Gnomad ASJ exome
AF:
0.300
Gnomad EAS exome
AF:
0.145
Gnomad FIN exome
AF:
0.222
Gnomad NFE exome
AF:
0.279
Gnomad OTH exome
AF:
0.257
GnomAD4 exome
AF:
0.256
AC:
373983
AN:
1461834
Hom.:
49160
Cov.:
35
AF XY:
0.256
AC XY:
185971
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.102
AC:
3401
AN:
33480
American (AMR)
AF:
0.273
AC:
12204
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.296
AC:
7732
AN:
26134
East Asian (EAS)
AF:
0.173
AC:
6862
AN:
39700
South Asian (SAS)
AF:
0.195
AC:
16853
AN:
86256
European-Finnish (FIN)
AF:
0.221
AC:
11785
AN:
53414
Middle Eastern (MID)
AF:
0.258
AC:
1490
AN:
5766
European-Non Finnish (NFE)
AF:
0.269
AC:
298889
AN:
1111966
Other (OTH)
AF:
0.245
AC:
14767
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
17455
34911
52366
69822
87277
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9798
19596
29394
39192
48990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.222
AC:
33770
AN:
152176
Hom.:
4229
Cov.:
33
AF XY:
0.220
AC XY:
16333
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.108
AC:
4495
AN:
41540
American (AMR)
AF:
0.284
AC:
4339
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.287
AC:
995
AN:
3470
East Asian (EAS)
AF:
0.155
AC:
801
AN:
5184
South Asian (SAS)
AF:
0.191
AC:
920
AN:
4824
European-Finnish (FIN)
AF:
0.216
AC:
2284
AN:
10592
Middle Eastern (MID)
AF:
0.276
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
0.278
AC:
18890
AN:
67986
Other (OTH)
AF:
0.257
AC:
541
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1332
2665
3997
5330
6662
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
356
712
1068
1424
1780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.265
Hom.:
10902
Bravo
AF:
0.221
Asia WGS
AF:
0.169
AC:
590
AN:
3478
EpiCase
AF:
0.284
EpiControl
AF:
0.282

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 30, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Tyr1176Tyr in exon 26 of JAG1: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 28% (18682/66732) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac. broadinstitute.org; dbSNP rs1051421). -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Alagille syndrome due to a JAG1 point mutation Benign:2
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Isolated Nonsyndromic Congenital Heart Disease Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Deafness, congenital heart defects, and posterior embryotoxon Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Tetralogy of Fallot Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 24, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
7.8
DANN
Benign
0.95
PhyloP100
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1051421; hg19: chr20-10620275; COSMIC: COSV54754834; COSMIC: COSV54754834; API